Sanhua Hongdao Investment
VC Fund
Sanhua Hongdao Investment is a VC fund focused on Health Care and Biotechnology. Sanhua Hongdao Investment
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sanhua Hongdao Investment invests in
Stages Sanhua Hongdao Investment invests in
Countries Sanhua Hongdao Investment invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Zhang Shaobo
|
|||
Investment Focus
Industry
- Health Care 3 (75%)
- Biotechnology 3 (75%)
- Pharmaceutical 2 (50%)
- Product Research 2 (50%)
- Medical 1 (25%)
Stage
- Series B 3 (75%)
- Series C 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Zhang Shaobo
Director & Assistant
|
Director & Assistant | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
YZY Bio
|
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions. | $38.7M / Series B / Sep 13, 2021 | |
Ab&B Biotech
|
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines. | $92.7M / Series C / Jul 16, 2021 | |
ChipON
|
Xinwang Microelectronics is a high-tech enterprise focusing on the research and development of highly reliable and high-quality 8-bit MCU and 32-bit MCU&DSP based on the independent IP KungFu core architecture. So far, it has successfully delivered KF8F, KF8L, KF8A, KF8TS, KF8S, KF32A, KF32F, KF32L, KF32LS and other products to the professionalchip application market, as well as ChipON IDE integrated development environment, ChipON PRO programming software, KungFu Minipro simulation programmer, and real realization From chip core design to tool development, the entire ecological chain has its own IP. | $50.4M / Series B / Mar 08, 2021 | |
TYK Medicines
|
It is an international innovative biotechnology high-tech company focuses on the research and development of new tumor drugs. | $36.1M / Series B / Dec 15, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sanhua Hongdao Investment invest in?
Sanhua Hongdao Investment invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B and Series C stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sanhua Hongdao Investment?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sanhua Hongdao Investment?
The team at Sanhua Hongdao Investment includes Zhang Shaobo (Director & Assistant). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
